OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME (OMAS) DUE TO ORGANOPHOSPHATE TOXICITY: CASE REPORT OF A RARE ASSOCIATION
DOI:
https://doi.org/10.55519/JAMC-01-13103Keywords:
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS), Organophosphate Toxicity, Opsoclonus, Myoclonus, Ataxia.Abstract
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) is a rare neurological disorder characterized by severe ataxia, multifocal muscle jerky movements and rapid eye oscillatory movements rarely seen as a consequence of organophosphate exposure. A 19-year-old gentleman presented with 2-day history of sudden onset uncontrollable jerky movements of all four limbs, dizziness and vertigo, difficulties in sitting and walking characterized by side-way swaying and increased tendency to fall. There was history of palpitations, vomiting, diarrhea, increased urination, lacrimation and salivation. Four days prior to presentation, there was accidental exposure to chlorpyrifos. On examination, pooling of tears, dribbling of saliva, hypertension, tachycardia, miosis, opsoclonus, myoclonus and ataxia were noted. He was admitted and started on intravenous atropine. MRI scan was done which demonstrated normal cerebellum. He was diagnosed with OMAS caused by Organophosphate Toxicity. By the time of discharge, he was clinically stable and asymptomatic.
References
1. Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Kruer MC. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol 2022;269(2):750–7.
2. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996;19(1):1–47.
3. Zhang X, Yan W, Song Y, Zhu H, Sun Y. Adult-onset idiopathic opsoclonus-myoclonus syndrome. Arq Bras Oftalmol 2023;87(4):e2022–0024.
4. Khadilkar S, Benny R. Opsoclonus myoclonus ataxia syndrome. Neurol India 2018;66(5):1293–4.
5. Kang BH, Kim JI. Opsoclonus-myoclonus syndrome associated with mumps virus infection. J Clin Neurol 2014;10(3):272–5.
6. Scott KM, Parker F, Heckmann JM. Opsoclonus-myoclonus syndrome and HIV-infection. J Neurol Sci 2009;284(1-2):192–5.
7. Sanguinetti SY, Ramdhani RA. Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19). J Neuroophthalmol 2021;41(3):e288–9.
8. Haridas A, Ravi P. Opsoclonus-myoclonus syndrome caused by organophosphate poisoning. Pract Neurol 2023;23(3):243–5.
9. Verheyen J, Stoks R. Current and future daily temperature fluctuations make a pesticide more toxic: Contrasting effects on life history and physiology. Environ Pollut 2019;248:209–18.
10. Robb EL, Baker MB. Organophosphate Toxicity. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470430/
11. Jokanović M. Neurotoxic effects of organophosphorus pesticides and possible association with neurodegenerative diseases in man: A review. Toxicology 2018;410:125–31.
12. Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Braga MF. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy. Neurobiol Dis 2020;133:104406.
13. Myhrer T, Aas P. Choice of approaches in developing novel medical countermeasures for nerve agent poisoning. Neurotoxicology 2014;44:27–38.
14. Walton EL. Pralidoxime and pesticide poisoning: A question of severity? Biomed J 2016;39(6):373–5.
15. Cantarín-Extremera V, Jiménez-Legido M, Aguilera-Albesa S, Hedrera-Fernández A, Arrabal-Fernández L, Gorría-Redondo N, et al. Opsoclonus-myoclonus syndrome: Clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort. Neurologia (Engl Ed) 2023;38(2):93–105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dur-e-Sabeh, Nauman Ismat Butt, Muhammad Sohail Ajmal Ghoauri, Asfand Yar Ali, Fahad Qaisar, Muhammad Umair Javed
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
